Jeremy Slone: Congratulations to Bella Ehrlich, Asya Agulnik, Michael McNeil and everyone involved with this very important project to better understand treatment-related mortality (TRM) for children with cancer in LMICs.
Quoting Jeremy Slone, Associate Member at St. Jude Children’s Research Hospital, shared a recent post by St. Jude Children’s Research Hospital on LinkedIn, adding:
”Congratulations to Bella Ehrlich, Dr. Asya Agulnik, Dr. Michael McNeil and everyone involved with this very important project to better understand treatment-related mortality (TRM) for children with cancer in LMICs. This data can help inform the development of interventions to address the main causes of TRM and improve survival of pediatric cancer around the world.”
Quoting the post by St. Jude Children’s Research Hospital:
“When medical student Bella Ehrlich started working in the St. Jude Department of Global Pediatric Medicine, she and her colleagues noted a lack of data on the scope and scale of treatment-related mortality in low- and middle-income countries.
In finding and publishing that data, the team discovered that nearly 7% of children who begin cancer treatment in low- and middle-income countries die from treatment-related causes. This makes up 1/3 of childhood cancer deaths. The statistic contrasts with high-income countries where only 3-5% of children with cancer die from treatment-related causes.
Ninety percent of children with cancer live in low- and middle-income countries where 5-year survival is below 20%. The study highlights how supportive care interventions could make a significant impact on improving mortality rates. Pediatric Early Warning Systems (PEWS) are one supportive care intervention that St. Jude researchers and their colleagues in Latin America have shown can save lives.”
For the article click here.
Source: Jeremy Slone/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023